Source of infection in young infants hospitalized with Bordetella pertussis;Fuente de infección de Bordetella pertussis en lactantes hospitalizados por coqueluche

Revista Medica de Chile

Volumn 139, Issue 4, 2011, Pages 448-454

  Pérez, Cecilia Perret ^a,b   Viviani, Tamara ^a,c   Peña, Anamaría ^a,c   Abarca, Katia ^a,b   Ferrés, Marcela ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Rheumatology Service   (Chile)

^c HOSPITAL DR SÓTERO DEL RÍO   (Chile)

Author keywords

Bordetella pertussis; Infant; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CHILE; CONTACT EXAMINATION; DISEASE TRANSMISSION; FAMILY SIZE; FEMALE; GENETICS; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PERTUSSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RISK FACTOR; VACCINATION;

ADOLESCENT; ADULT; AGED; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CHILE; CONTACT TRACING; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 79961041300     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872011000400005     Document Type: Article

References (33)

1. WHO home page. Immunization, Vaccine and Biologicals. Pertussis. (updated 25 January 2008). Disponible en: http://www.who.int/immunization/topics/pertussis/en/ index.html. (Consultado el 16 de abril de 2010).
2. rd Ed 1999, 293-344.
3. Olea A. Ministerio de Salud de Chile. Departamento de Epidemiología, página web. Tos Ferina. El Vigía N° 24. Página 59. Disponible en: http://epi.minsal.cl/epi/html/ elvigia/Vigia24.pdf. (Consultado el 16 de abril de 2010).
4. de Melker H, Schellenkens JEP, Neppelenbroek SE, Mooi FR, Rümke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: Observations on surveillance data. Emerg Infect Dis 2000; 6: 348-57.
5. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med 1988; 296 (6622): 612-4.
6. Edwards K. Overview of Pertussis. Focus on epidemiology, sources of infection and long term protection after infant vaccination. Pediatr Infect Dis J 2005; 24: S104-8.
7. Mertsola J, Ruuskanen O, Eerola E, Viljann MK. Intrafamiliar spread of pertussis. J Ped 1983; 103: 359-63.
8. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161: 480-6.
9. Kowalzik F, Barbosa AP, Fernández VR, Carvalho PR, Avila-Aguero ML, Goh DY, et al. Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and their Household Contacts. Ped Infect Dis J 2007; 26: 238-42.
10. Baptista P, Magalhaes V, Rodrigues L, Rocha MA, Pimentel AM, et al. Source of Infection in household transmission of culture-confirmed pertussis in Brazil. Ped Infect Dis J 2005; 24: 1027-8.
11. Perret PC. Pertussis vaccine for adolescents and adults. Rev Chil Infect 2006; 23: 257-60.
12. Pichichero M, Rennels M, Edwards K, Blatter MM, Marshall GS, Bologa M, et al. Combined Tetanus, Diphtheria, and 5 component Pertussis Vaccine for use in Adolescents and Adults. JAMA 2005; 293: 3003-11.
13. Van Damme P, Burgess M. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis in adults. Vaccine 2004; 22: 304-8.
14. Ward J, Cherry J, Chang S, Partridge S, Lee H, Treanor J, et al. Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults. N Engl J Med 2005; 353: 1555-63.
15. Abarca K, Valdivieso F, Potin M, Ibáñez I, Vial P. Inmunogenicidad y seguridad de una vacuna difteria, tétanos, pertussis acelular de contenido antigénico reducido (dTpa) en niños de 10 a 11 años de edad y en adultos. Rev Med Chile 2002; 130: 502-10.
16. Kösters K, Reischl U, Schmetz J, Riffelmann M, Wirsing von König CH. Real-Time LightCycler PCR for Detection and Discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 2002; 40: 1719-22.
17. CDC. Pertussis-United States 1997-2000. MMWR 2002; 51: 73-6.
18. WHO home page. Immunization, surveillance, assessment and monitoring. WHO-recommended surveillance standard of pertussis. Disponible en: http:// www.who.int/immunization_monitoring/diseases/ pertussis_surveillance/en/index.html (Consultado el 16 de abril de 2010).
19. o B51/04, 9 Febrero 2007. Disponible en: http://epi. minsal.cl/epi/html/normas/circul/Circular-Coqueluche. pdf (Consultado el 16 de abril de 2010).
20. Halperin SA, Wang E. E, Law B, Mills E, Morris R, Déry P, et al. Epidemiological features of Pertussis in Hospitalized Patients in Canada, 1991-1997: Report of the Immunization Monitoring Program-Active IMPAC T. Clin Infect Dis 1999; 28: 1238-43.
21. Bisgard K, Pascual B, Ehresmann K, Miller CA, Cianfrini C, Jennings CE et al. Infant Pertussis. Who was the Source? Ped Infect Dis J 2004; 23: 985-9.
22. Wendelboe A, Njamkepo E, Bourillon A, Floret D, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to Young Infants. Pediatr Infect Dis J 2007; 26: 293-9.
23. Baptista P, Magalhães V, Rodrigues L. Children with pertussis inform the investigation of other pertussis cases among contacts. BMC Pediatrics 2007; 7: 21
24. Thomas PF, McIntyre PB, Jalaludin BB. Survey of pertussis morbidity in adults in western Sydney. Med J Aust 2000; 173: 74-6.
25. De Serres G, Shadmani R, Duval B, Boulianne N, Déry P, Douville Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174-9.
26. He Q, Mertsola J, Soini H, Viljanen MK. Sensitive and specific polymerase chain reaction assay for detection of Bordetella pertussis in nasopharyngeal specimens. J Pediatr 1994; 124: 421-6.
27. Perret C, Vial P, Viviani T, González P, Montiel F, Riedel I, et al. Etiología del Síndrome Coqueluchoideo y rendimiento de técnicas de diagnóstico para Bordetella pertussis en pacientes hospitalizados. Rev Chil Infect 1999; 16: 17-26.
28. Birkebaek NH, Kristiansen M, Seefeldt T, Degn J, Moller A, Heron I, et al. Bordetella pertussis and chronic cough in adults. Clin Infect Dis 1999; 29: 1239-42.
29. Marchant CD, Loughlin AM, Lett SM, Todd CW, Wetterlow LH, Bicchieri R, et al. Pertussis in Massachusetts, 1981--1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 1994; 169: 1297-305.
30. Fry NK, Tzivra O, Li YT, et al. Laboratory diagnosis of pertussis infections: the rol of PCR and serology. J Med Microbiol 2004; 53 (Pt 6): 519-25.
31. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against Pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38: 800-6.
32. Taranger J, Trollfors B, Bergfors E, Knutsson N, Sundh V, Lagerga T, et al. Mass Vaccination of Children with Pertussis Toxoid-Decreased Incidence in Both Vaccinated and Nonvaccinated Persons. Clin Infect Dis 2001; 33: 1004-9.
33. Quian J, Cerisola A, Russomano F, Fernández A, Cappeta M, Uriarte R et al. [Infections with Bordetella pertussis in children under one year old hospitalized and their household contacts]. Arch Pediatr Urug 2006; 77: 229-36.